We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+10.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$36.2B
AUM Growth
+$2.03B
(+6%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
14.34%
Holding
2,349
New
214
Increased
749
Reduced
1,086
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$165M |
| 2 |
American Electric Power
AEP
|
+$143M |
| 3 |
Duke Energy
DUK
|
+$123M |
| 4 |
Medtronic
MDT
|
+$121M |
| 5 |
Eli Lilly
LLY
|
+$86.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$211M |
| 2 |
Chevron
CVX
|
+$186M |
| 3 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$169M |
| 5 |
ExxonMobil
XOM
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.91% |
| 2 | Financials | 14.92% |
| 3 | Technology | 12.39% |
| 4 | Consumer Discretionary | 8.32% |
| 5 | Consumer Staples | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
T. Rowe Price
TROW
$21.8B
| $529K | ﹤0.01% |
4,847
-7,186
| -60% | -$813K |
|
|
SRCL
1352
DELISTED
Stericycle Inc
SRCL
| $527K | ﹤0.01% |
10,571
-3,649
| -26% | -$174K |
|
1353
CBRE Group
CBRE
$40.1B
| $525K | ﹤0.01% |
6,824
-2,227
| -25% | -$164K |
|
1354
Ingevity
NGVT
$2.35B
| $523K | ﹤0.01% |
7,427
-880
| -11% | -$62K |
|
1355
Neogen
NEOG
$2.74B
| $522K | ﹤0.01% |
34,288
-156,421
| -82% | -$2.23M |
|
1356
AES
AES
$10.6B
| $522K | ﹤0.01% |
18,154
-2,713
| -13% | -$73.1K |
|
1357
Ziff Davis
ZD
$2.01B
| $520K | ﹤0.01% |
6,579
-591
| -8% | -$47.5K |
|
1358
Adient
ADNT
$1.41B
| $515K | ﹤0.01% |
14,848
-1,259
| -8% | -$44K |
|
|
HTB
1359
HomeTrust Bancshares
HTB
$772M
| $512K | ﹤0.01% |
21,185
+18,660
| +739% | +$447K |
|
1360
Protagonist Therapeutics
PTGX
$9.24B
| $511K | ﹤0.01% |
+46,808
| New | +$395K |
|
|
TBNK
1361
DELISTED
Territorial Bancorp Inc.
TBNK
| $510K | ﹤0.01% |
21,242
+1,074
| +5% | +$22.6K |
|
1362
Cardinal Health
CAH
$54.1B
| $509K | ﹤0.01% |
6,625
-1,297
| -16% | -$98.5K |
|
1363
NCR Voyix
VYX
$982M
| $505K | ﹤0.01% |
35,172
+8,513
| +32% | +$113K |
|
1364
Sabesp
SBS
$18.6B
| $502K | ﹤0.01% |
+242,872
| New | +$513K |
|
|
AMED
1365
DELISTED
Amedisys
AMED
| $501K | ﹤0.01% |
5,999
+544
| +10% | +$49K |
|
1366
Reynolds Consumer Products
REYN
$4.73B
| $498K | ﹤0.01% |
16,623
-27,976
| -63% | -$840K |
|
1367
Nomad Foods
NOMD
$1.54B
| $497K | ﹤0.01% |
28,835
| – | – |
|
1368
Ericsson
ERIC
$32.7B
| $496K | ﹤0.01% |
+85,000
| New | +$511K |
|
1369
Coty
COTY
$2.32B
| $494K | ﹤0.01% |
57,752
-4,845
| -8% | -$35.6K |
|
1370
Byrna Technologies
BYRN
$86.8M
| $489K | ﹤0.01% |
62,371
+2,371
| +4% | +$17.7K |
|
1371
Assembly Biosciences
ASMB
$519M
| $486K | ﹤0.01% |
31,136
-3
| -0% | -$51 |
|
1372
Ally Financial
ALLY
$12.3B
| $483K | ﹤0.01% |
19,742
-565
| -3% | -$15K |
|
1373
C3.ai
AI
$1.7B
| $482K | ﹤0.01% |
43,107
-7,662
| -15% | -$95.9K |
|
1374
Quest Diagnostics
DGX
$27.3B
| $480K | ﹤0.01% |
3,067
-283
| -8% | -$40.7K |
|
1375
Home BancShares
HOMB
$5.95B
| $480K | ﹤0.01% |
21,048
-11,157
| -35% | -$271K |
|
Similar funds
Federated Hermes's Q4 2022 Portfolio in Review
As of Q4 2022, Federated Hermes held 2,349 positions worth $36.2B, up 6% from $34.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes's Q4 2022 filing shows 214 new, 749 increased, 1,086 reduced and 196 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M. The largest sale was Amgen, an estimated $211M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M.
- Federated Hermes added most to LyondellBasell Industries in Q4 2022, an estimated $165M increase.
- Federated Hermes's biggest Q4 2022 reduction was Amgen, cutting an estimated $211M.
- Federated Hermes fully exited Akouos Inc in Q4 2022, selling an estimated $27M.
- Federated Hermes's ten largest holdings make up 14% of its $36.2B portfolio in Q4 2022.
- Federated Hermes opened 214 new positions and closed 196 in Q4 2022.
- Federated Hermes's portfolio value rose 6% quarter-over-quarter to $36.2B.
Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.